A Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's Disease
← catalyst calendarNCT07485153 · readout ≤ 42 d
Sponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
35estimated
Sites
1
Country
Singapore
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Mar 2026 | estimated | When the study began enrolling |
| Primary completion | Sep 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Sep 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2026-03-20 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-03-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Alzheimer's Disease
- Early Alzheimer's Disease
- Memory Problems
Interventions
- Device: Mobile EEG — also filed as Somfit
- Device: Activity Monitor — also filed as ActiGraph LEAP Activity Monitor
- Device: Sleep Study — also filed as Polysomnography
Primary outcome
what the primary-completion date above is the date OFPercentage of Agreement between Participants with the Same Results in Sleep Staging Using EEG and Sleep Study
measured Night 1, Night 2
Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed